You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Moodys
Merck
Mallinckrodt
Baxter

Last Updated: February 19, 2020

DrugPatentWatch Database Preview

Accord Hlthcare Company Profile


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ACCORD HLTHCARE, and what generic and branded alternatives to ACCORD HLTHCARE drugs are available?

ACCORD HLTHCARE has one hundred and thirteen approved drugs.

There are ten tentative approvals on ACCORD HLTHCARE drugs.

Summary for Accord Hlthcare
US Patents:0
Tradenames:98
Ingredients:95
NDAs:113

Drugs and US Patents for Accord Hlthcare

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE ethinyl estradiol; norethindrone TABLET, CHEWABLE;ORAL 207066-001 Mar 29, 2017 AB RX No No   Start Trial   Start Trial
Accord Hlthcare ESCITALOPRAM OXALATE escitalopram oxalate TABLET;ORAL 202389-001 Sep 11, 2012 AB RX No No   Start Trial   Start Trial
Accord Hlthcare LISINOPRIL lisinopril TABLET;ORAL 202554-006 Jul 30, 2013 AB RX No No   Start Trial   Start Trial
Accord Hlthcare IRINOTECAN HYDROCHLORIDE irinotecan hydrochloride INJECTABLE;INJECTION 079068-001 Nov 21, 2008 AP RX No No   Start Trial   Start Trial
Accord Hlthcare MYCOPHENOLIC ACID mycophenolic acid TABLET, DELAYED RELEASE;ORAL 202555-001 Aug 23, 2017 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Dow
Medtronic
McKesson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.